Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A public open day to showcase groundbreaking medical research that is taking place in Oxford across a range of conditions such as cancer and diabetes will be held at the John Radcliffe Hospital (JR) this month.

Talks, a tour of clinical facilities, stalls and a debate about the opportunities and challenges of sharing patient data will feature in the NIHR Oxford Biomedical Research Centre (BRC) Celebrating Biomedical Research Open Day on Thursday, April 21.

The hospital’s Tingewick Hall will be packed with more than 30 stalls, including hands on exhibits, to demonstrate the work of the BRC, a partnership between the University of Oxford and Oxford University Hospitals NHS Foundation Trust (OUH) to fund and support medical research.

The BRC supports research across 14 Themes including cancer, diabetes, genetics, stroke, infection, surgery, vaccines and others.

Attractions will include a new 55-inch touchscreen computer being used to view cells up close for teaching at the JR, a mobile phone app to assess general fitness, a quiz on which foods contain the most iron, a microscope to view blood slides showing acute leukaemia and spectacles that simulate eye diseases.

Doctors and researchers will be on hand to answer questions about their work with the BRC, which has benefited from more than £150m of investment from the National Institute for Health Research (NIHR) since 2007.

The day will begin with a public tour of the University of Oxford’s Acute Vascular Imaging Centre, at the JR. Here, emergency cases who are eligible for study are taken to a MRI scanner during or after treatment in either the hospital’s Cardiac Catheter Labs or the Emergency Department to study the impact of treatments in real time on the body.

Exhibitions, including the Surgical Intervention Trials Unit and the ACST-2 team from the Nuffield Department of Surgical Sciences, will open in Tingewick Hall, in the hospital’s academic block, from midday to 5pm.

At 12.45pm to 1.45pm a debate “Good to share? Data, research, privacy and the NHS” will be held in adjacent Lecture Theatre 2 on the exciting but often challenging issues around mass sharing of patient data to support research and improve patient care.

Audience members will be encouraged to ask questions of panellists, drawn from a spectrum of viewpoints on the issue, which many clinicians believe is vital to making big leaps in our understanding of disease.

Professor Keith Channon, Director of the Oxford BRC and Dr Tony Berendt, Medical Director, OUH will give short keynote speeches at 2pm.

They will be joined by Dr Caroline Hargrove, Technical Director at McLaren Applied Technologies who will talk about how data analysis and simulation tools for motorsport are now driving innovation in surgery and patient care.

Talks by clinicians will then examine some two major healthcare challenges facing research and take questions from the audience.

Professor Adrian Harris, of the University of Oxford Department of Oncology, will talk about “New ways to Treat Cancer” from 3pm to 3.30pm while Dr Matthew Snape, Jenner Investigator and Oxford BRC Consultant in General Paediatrics and Vaccinology, Department of Paediatrics, University of Oxford will speak on “Meningitis Vaccines – can we do more?” from 3.45pm to 4.15pm.

Booking is recommended for all events other than the exhibits at oxfordbrc.nihr.ac.uk or 01865 743341.

Similar stories

New reporting guidelines to bridge the gap from development to implementation in clinical artificial intelligence

Innovation Research

In a correspondence to Nature Medicine, a team of Oxford-led academics describe upcoming new guidelines to improve the reporting of early clinical stage (or first-with-human) evaluation of decision support systems driven by artificial intelligence.

NDS project awarded Public Engagement Seed Funding 2020-21

Awards and appointments Public engagement

Seven projects from the Medical Sciences Division, including a project from the Nuffield Department of Surgical Sciences, have received funding in the 2020-21 round of the Public Engagement with Research Seed Fund for innovative projects to engage the public with medical research.

Cochrane ENT awarded NIHR funding for COVID-19 project

Awards and appointments Coronavirus COVID-19 Research

Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.

First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy

Coronavirus COVID-19 Publication Research

Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.

Applications for Oxford-Wolfson-Marriott-Patel Scholarship now open

Awards and appointments Department Research

The Nuffield Department of Surgical Sciences (NDS) are pleased to confirm that one scholarship will be available for Home (UK) and Republic of Ireland (ROI) candidates for the DPhil in Surgical Sciences, starting in Michaelmas Term 2021.

Oxford University breakthrough on global COVID-19 vaccine

Coronavirus COVID-19 Research

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.